EMAIL THIS PAGE TO A FRIEND

Pharmaceutical research

Uptake and cytotoxicity of docetaxel-loaded hyaluronic acid-grafted oily core nanocapsules in MDA-MB 231 cancer cells.


PMID 24643931

Abstract

It is hypothesized that docetaxel (Doc)-loaded hyaluronic acid (HA)-polyethylene glycol/poly(ε-caprolactone)-grafted oily core nanocapsules (NCs) can enhance the drug cytotoxicity and uptake in CD44 expressing breast cancer (BC) cells (MDA-MB 231). NCs were prepared, optimized and characterized by dynamic light scattering, transmission electron microscopy (TEM), and powder X-ray diffraction (PXRD). In vitro cytotoxicity tests [MTS, level of reactive oxygen species (ROS) and level of reduced glutathione (GSH)] were performed in BC cells. The contribution of CD44 to the NCs cellular uptake was elucidated using an anti CD44 antibody blockage and a CD44 negative NIH3T3 cell line. The optimum formulation of Doc-loaded HA oily core NCs had respective mean diameter, polydispersity, and drug encapsulation efficiency of 224.18xa0nm, 0.32, and 60.38%. The NCs appeared spherical with low drug crystallinity, while the drug release data fitted to first order equation. Compared to that of ungrafted NCs, the cytotoxicity of Doc-loaded HA-grafted NCs was significantly enhanced (p<0.05). A decrease of the intracellular level of ROS was reversely correlated with that of GSH. Interestingly, the cellular internalization of HA-grafted NCs mediated CD44 was dramatically enhanced (3 to 4-fold) with respect to the absence of specific biomarker or targeting ligand. The use of HA-grafted NCs enhanced the selective drug payload, cytotoxicity and uptake in MDA-MB 231 cells. Therefore, it could be a promising template for safe and effective delivery of Doc and similar chemotherapeutic agents in cancer cells.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

GW22755 Anti-CD44 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
SAB1405590
Anti-CD44 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA005785
Anti-CD44 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4300691
Anti-CD44 antibody produced in rabbit, affinity isolated antibody
C4528
Chlorobimane
C10H11ClN2O2
69899
Monochlorobimane, suitable for fluorescence, ≥70.0% (HPCE)
C10H11ClN2O2
C7923 Monoclonal Anti-CD44 antibody produced in mouse, clone A3D8, purified immunoglobulin, buffered aqueous solution
SAB1402714
Monoclonal Anti-CD44 antibody produced in mouse, clone 1E1, purified immunoglobulin, buffered aqueous solution
SAB4700179 Monoclonal Anti-CD44 antibody produced in mouse, clone MEM-85, purified immunoglobulin, buffered aqueous solution
SAB4700184 Monoclonal Anti-CD44 antibody produced in mouse, clone MEM-263, purified immunoglobulin, buffered aqueous solution
SAB4700188 Monoclonal Anti-CD44 antibody produced in rat, clone IM7, purified immunoglobulin, buffered aqueous solution
03450
N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride, purum, ≥98.0% (AT)
C8H17N3 · HCl
PHR1344
Trehalose, Pharmaceutical Secondary Standard; Certified Reference Material
C12H22O11 · 2H2O
1673715
Trehalose, United States Pharmacopeia (USP) Reference Standard
C12H22O11 · 2H2O